Immunome Statistics

Total Valuation

Immunome has a market cap or net worth of $1.81 billion. The enterprise value is $1.54 billion.

Market Cap	1.81B
Enterprise Value	1.54B

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Immunome has 91.71 million shares outstanding. The number of shares has increased by 47.92% in one year.

Current Share Class	91.71M
Shares Outstanding	91.71M
Shares Change (YoY)	+47.92%
Shares Change (QoQ)	+1.09%
Owned by Insiders (%)	2.09%
Owned by Institutions (%)	85.29%
Float	75.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	161.95
Forward PS	650.04
PB Ratio	6.87
P/TBV Ratio	6.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	159.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.90, with a Debt / Equity ratio of 0.02.

Current Ratio	8.90
Quick Ratio	8.67
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -93.04% and return on invested capital (ROIC) is -53.25%.

Return on Equity (ROE)	-93.04%
Return on Assets (ROA)	-46.48%
Return on Invested Capital (ROIC)	-53.25%
Return on Capital Employed (ROCE)	-77.20%
Revenue Per Employee	$82,025
Profits Per Employee	-$1.89M
Employee Count	118
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +45.94% in the last 52 weeks. The beta is 2.18, so Immunome's price volatility has been higher than the market average.

Beta (5Y)	2.18
52-Week Price Change	+45.94%
50-Day Moving Average	16.01
200-Day Moving Average	10.72
Relative Strength Index (RSI)	63.67
Average Volume (20 Days)	1,329,156

Short Selling Information

The latest short interest is 14.32 million, so 15.62% of the outstanding shares have been sold short.

Short Interest	14.32M
Short Previous Month	15.09M
Short % of Shares Out	15.62%
Short % of Float	19.06%
Short Ratio (days to cover)	10.50

Income Statement

In the last 12 months, Immunome had revenue of $9.68 million and -$222.74 million in losses. Loss per share was -$2.81.

Revenue	9.68M
Gross Profit	-164.73M
Operating Income	-206.85M
Pretax Income	-222.74M
Net Income	-222.74M
EBITDA	-204.56M
EBIT	-206.85M
Loss Per Share	-$2.81

Full Income Statement

Balance Sheet

The company has $272.64 million in cash and $4.01 million in debt, giving a net cash position of $268.63 million or $2.93 per share.

Cash & Cash Equivalents	272.64M
Total Debt	4.01M
Net Cash	268.63M
Net Cash Per Share	$2.93
Equity (Book Value)	263.92M
Book Value Per Share	2.88
Working Capital	248.48M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$185.03 million and capital expenditures -$6.81 million, giving a free cash flow of -$191.84 million.

Operating Cash Flow	-185.03M
Capital Expenditures	-6.81M
Free Cash Flow	-191.84M
FCF Per Share	-$2.09

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,137.10%
Pretax Margin	-2,301.30%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunome does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-47.92%
Shareholder Yield	-47.92%
Earnings Yield	-12.29%
FCF Yield	-10.59%

Analyst Forecast

The average price target for Immunome is $26.89, which is 36.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$26.89
Price Target Difference	36.08%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	91.68%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Immunome has an Altman Z-Score of 8.6 and a Piotroski F-Score of 2.

Altman Z-Score	8.6
Piotroski F-Score	2